BIOMEDICA CROBIOMEDICA CRO
  • +38 (068) 150 70 04
  • office@biomedica-cro.com
  • Biospecimens
    • Tissue Samples
    • Blood samples
    • Other Biofluids
    • Inventory
  • Disease Areas
  • Ethics
  • Blog
  • About us
  • Contacts
  • ENEN
    • UAUA
Search
SEND REQUEST
  • Biospecimens
    • Tissue Samples
    • Blood samples
    • Other Biofluids
    • Inventory
  • Disease Areas
  • Ethics
  • Blog
  • About us
  • Contacts
  • Home
  • Blog
  • New COVID-19 vaccine development and how BIOMEDICA CRO helps to move science forward

New COVID-19 vaccine development and how BIOMEDICA CRO helps to move science forward

New COVID-19 vaccine development and how BIOMEDICA CRO helps to move science forward

16.09.2022
BIOMEDICA CRO team is ready to provide you with high-quality human biospecimens and associated data from both hospitalized patients with confirmed COVID infection and healthy individuals.
admin2024-05-29T14:37:41+00:00

The new vaccine for SARS-CoV-2 is to target both the spike and nucleocapsid proteins – the review of the latest scientific news by BIOMEDICA CRO team

A large team of researchers at the University of Texas Medical Branch, working with two colleagues from the University of Pennsylvania Perelman School of Medicine and two with the Mayo Clinic, has developed a vaccine for COVID-19 that targets both the spike and nucleocapsid proteins in the SARS-CoV-2 virus.
The researchers created an mRNA-type vaccine that focused on both the S and N proteins and then injected it into test mice. They observed both a robust immune response and a short recovery period.

Scientists found that the virus was less able to damage the lungs, and the bivalent vaccine worked better than a strictly S-based vaccine in a control group. The team ran similar tests with hamsters and found similar results, which gives hope.
It is necessary to continue research involving human biospecimens in the future, considering all the mentioned-above facts.

Please find more information on the Science Translational Medicine website, research articles, “Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models”.

COVID-related biospecimens collection by BIOMEDICA CRO – we are here to help with your research!

BIOMEDICA CRO is proud to participate in research on new biomarkers, preclinical trials, drugs, and vaccine development.
Today we have collected more than 112000+ samples from subjects with various diseases through a broad network of partnered hospitals in Ukraine and supplied them globally to scientists from world-known pharmaceutical companies and research centers.

Our team is ready to provide you with high-quality human biospecimens and associated data from both hospitalized patients with confirmed SARS-CoV-2 infection and healthy individuals.
For instance, we can provide the following COVID-related biospecimens:

  • Various swabs (nasopharyngeal, oropharyngeal, etc.);
  • Saliva;
  • Whole blood;
  • Single- or double-spun plasma;
  • Buffy coat;
  • Serum;
  • Urine;
  • Stool, etc.

If you need a reliable partner to source human biospecimens, BIOMEDICA CRO is here to help. Together we can stop the pandemic!

Please email us to start our collaboration: office@biomedica-cro.com / LinkedIn.

Feel free to place a request for human biospecimens.

Share this post

Facebook Twitter LinkedIn
All publications
Multiple Myeloma research and the role of human biospecimens providers
Aspirin in cancer treatment – from supplying biospecimens to discovering new therapy types
  • Biospecimens
  • Disease Areas
  • Ethics
  • Blog
  • About us
  • Contacts

Privacy Policy | Terms of use

Linkedin

Site development mamontova design

BIOMEDICA CRO
© 2021 | All rights reserved

View the Inventory

Click on the button "Download the inventory" to review the list of ready-to-ship biospecimens.

Download the Inventory

Iryna Iurkova

Business Development Director

Ms. Iurkova is experienced in brand promotion, business development, marketing communications, and public relations. Prior to becoming Business Development Director for BIOMEDICA CRO, Iryna worked at Deloitte, Bayer, and AB InBev. She has a Master’s Degree in International Business Management. For the last seven years, Iryna has successfully worked in the field of human biospecimens, managing numerous complex projects.

Serhii Samsoniuk

Chief Executive Officer

Mr. Samsoniuk is a pharmaceutical expert with over 15 years of industry experience. Over the course of his career, he has held key leadership roles at both international and local companies, such as GlaxoSmithKline, B.Braun, and Sona Exim, overseeing strategic marketing, sales, and key account management. Before joining BIOMEDICA CRO team, he led business development efforts in the CCA+ region at Farmak, driven by a commitment to professional ethics and strategic partnership.

Anton Zubov - MD, BIOMEDICA CRO Co-Founder, Board Member

Anton Zubov

MD, BIOMEDICA CRO Co-Founder,
Board Member

Dr. Zubov has over 21 years of experience in the international pharmaceutical markets. He has held numerous leading positions in marketing, management and sales at Schering AG and Bayer Pharmaceuticals. He has made a career internationally with positions in Ukraine, Germany and Central Asia. In 2017, together with Dr. Kupnovitsky, he founded BIOMEDICA CRO and during the first years was its CINO. Dr. Zubov is currently a Marketing & Sales Director of the CIS Region in Farmak and Board Member of BIOMEDICA CRO Supervisory Board.

have any questions?

Send request

Fill out the form and we will contact you shortly

    Name

    E-mail

    Your message


    have any questions?

    Send request

    Please send us a message and we’ll be back to you shortly

      Name

      Company name

      E-mail

      Your message

      Ostap Kupnovitsky - PhD, MD, MBA, BIOMEDICA CRO Co-Founder, Chairman of the Supervisory Board

      Ostap Kupnovitsky

      PhD, MD, MBA,
      BIOMEDICA CRO Co-Founder,
      Chairman of the Supervisory Board

      Dr. Kupnovitsky has a vast experience in the pharmaceutical market. He was the Regional Director of Organon and Serono in Ukraine. In 2003, he became a Co-Founder and Director of Sona-Pharm, the firm that started its activity in Ukraine and has flourished into an international marketing company with its representatives throughout the CIS region. Since 2017, when BIOMEDICA CRO was founded, he has been a distinguished Chairman of its Supervisory Board.